WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-01·Latest →

Nike, Inc. (NKE) Stock Analysis

UW

NKE Equity Research — UNDERWEIGHT — July 2026

← MCDSBUX →

Rating date

Jul 1, 2026

40 days ago

Desk view

UW

5D move

—

Awaiting market data

Peer rank

67p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · NKE

Now I have all the data I need. Here is the analysis.

Desk rating

UW

Tactical UW · 12M UW

Horizon

Short to medium term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

UNDERWEIGHT

Catalysts

  • NKE is in a structural downtrend. The ~44% decline over 12 months, persistent trading below the declining 50-day SMA, and accelerating downside in June paint a clearly bearish picture.
  • The $40–$41 zone appears to be attracting dip-buying interest, evidenced by the volume spike on June 30 and the RSI recovery from 35.6 to 48.8.
  • Any bounce from here should be treated as counter-trend until NKE can reclaim its 50-day SMA (~$43.67 and falling). That level is the first resistance.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

NKE Research Note

Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

28 min read

WebserviceX · Agentic Research Desk

NKE Equity Research Note

Published Jul 1, 2026 · Desk view UNDERWEIGHT · Generated 2026-07-02T20:36:39Z · Maintained by Walter Vijayakumar · Methodology · Track record

NKE Stock Rating Summary

NKE bias

UNDERWEIGHT

Horizon

Short to medium term

NKE key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

NKE catalyst watch

NKE is in a structural downtrend. The ~44% decline over 12 months, persistent trading below the declining 50-day SMA, and accelerating downside in June paint a clearly bearish picture.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

—Awaiting market dataPeer 67p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:28.108119+00:00.

5D move

—

2026-07-01 → awaiting

Outcome

Awaiting market data

5D trend

+2.97%

Vol (20D ann.)

+37.08%

vs SPY: +1.26%

Close 43.06 → — (USD, vendor closes)

Batch scorecard · 2026-07-01 · NKE

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 9b574f0c…

No QC issues recorded.